每日經濟新聞(wen) 2022-08-17 16:26:36
每經(jing)AI快訊(xun),有投資者在投資者互動平(ping)臺提問:請問貴公司主打產品都是(shi)什么?占銷(xiao)售額的比例是(shi)多少?
葵花(hua)藥(yao)(yao)(yao)(yao)(yao)(yao)業(002737.SZ)8月17日在投資者互動平臺(tai)表示(shi),公司(si)“小葵花(hua)”兒(er)(er)童(tong)(tong)藥(yao)(yao)(yao)(yao)(yao)(yao)及(ji)“葵花(hua)”成人藥(yao)(yao)(yao)(yao)(yao)(yao)在市場(chang)上具有較(jiao)高銷售份額。目前,兒(er)(er)藥(yao)(yao)(yao)(yao)(yao)(yao)產(chan)品(pin)涉及(ji)兒(er)(er)童(tong)(tong)呼吸(xi)系統(tong)(tong)用(yong)藥(yao)(yao)(yao)(yao)(yao)(yao)、兒(er)(er)童(tong)(tong)消化(hua)系統(tong)(tong)用(yong)藥(yao)(yao)(yao)(yao)(yao)(yao)、兒(er)(er)童(tong)(tong)補益(yi)系統(tong)(tong)用(yong)藥(yao)(yao)(yao)(yao)(yao)(yao)、兒(er)(er)童(tong)(tong)罕見病用(yong)藥(yao)(yao)(yao)(yao)(yao)(yao)、兒(er)(er)童(tong)(tong)健(jian)康(kang)(kang)(kang)領域(yu)。主品(pin)包括小兒(er)(er)肺熱咳喘(chuan)口服液、小兒(er)(er)柴(chai)桂退(tui)熱顆(ke)粒、小兒(er)(er)氨酚黃(huang)那(nei)敏顆(ke)粒、金銀花(hua)露、小兒(er)(er)氨酚烷胺顆(ke)粒、小兒(er)(er)肺熱咳喘(chuan)顆(ke)粒、芪斛楂顆(ke)粒等(deng)。成人藥(yao)(yao)(yao)(yao)(yao)(yao)產(chan)品(pin)涵(han)蓋呼吸(xi)感冒(mao)系統(tong)(tong)用(yong)藥(yao)(yao)(yao)(yao)(yao)(yao)、消化(hua)系統(tong)(tong)用(yong)藥(yao)(yao)(yao)(yao)(yao)(yao)、風濕骨病用(yong)藥(yao)(yao)(yao)(yao)(yao)(yao)、心(xin)腦血管用(yong)藥(yao)(yao)(yao)(yao)(yao)(yao)、婦科用(yong)藥(yao)(yao)(yao)(yao)(yao)(yao)、補益(yi)用(yong)藥(yao)(yao)(yao)(yao)(yao)(yao)及(ji)健(jian)康(kang)(kang)(kang)產(chan)品(pin)。核心(xin)品(pin)種包括護(hu)肝片、胃(wei)康(kang)(kang)(kang)靈、美沙拉嗪、康(kang)(kang)(kang)婦消炎栓等(deng)。
(記者 畢陸名)
免責聲明:本文內容與數(shu)據僅供參考,不構成投(tou)資建議,使用前核實。據此操作,風險自擔。
如需轉載請與《每日經濟新聞》報社聯系。
未(wei)經(jing)《每日(ri)經(jing)濟新聞》報社授權(quan),嚴(yan)禁轉(zhuan)載或鏡像,違者(zhe)必究。
讀者(zhe)熱(re)線:4008890008
特別提醒(xing):如果我們使用了您的圖片,請作者與本站聯系索取(qu)稿酬(chou)。如您不希望作(zuo)(zuo)品(pin)出現在本(ben)站(zhan),可聯系我們要求(qiu)撤下(xia)您的(de)作(zuo)(zuo)品(pin)。
歡迎關注每日經濟新聞APP